Coultreon
4 known investors
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Founders & leadership
PR
Pierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder
MD
Marie De VulderChief Legal Officer Co-founder
GP
Guy PeetersChief Financial Officer Co-founder
JG
John-Paul GallivanHead of Development Co-founder
FK
Fabrice KolbHead of Immunology Co-founder
PP
Pieter PeetersOperating & Technology Officer Co-founder
FG
François GonzalvezCo-founder
SV
Sandrine VendevilleCo-founder
JK
Joost KolkmanCo-founder
Investors · 4
In the news
- Coultreon Biopharma secures $125M to advance SIK3 drugbioxconomy.com · 2026
- Coultreon raises $125M for immune resiliencelongevity.technology · 2026
- Big Pharma–backed Coultreon bags $125M series A to unlock alternative immune pathway - BioSpacebiospace.com · 2026
- Coultreon banks $125M to support testing of former Galapagos immune drug | BioPharma Divebiopharmadive.com · 2026
- Rebranded Belgian biotech lands $125M for rescued Galapagos drug candidatesfiercebiotech.com · 2026
- Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipelinecoultreon.com · 2026